16 November 2023

Augmentum Fintech plc

Notice of Interim Results

Augmentum Fintech plc (LSE: AUGM) (the "Company" or "Augmentum"), Europe's leading publicly listed fintech fund,will announce its interim results for the six month period to 30 September 2023 on 28 November 2023.

Analyst Call

The Manager will host a conference call for analysts at 10:30 a.m. on 28 November 2023.

To register to join the call please email: [email protected]

Investor Meet Company Presentation

The Company will host an online investor presentation at 9:00 a.m. on 30 November 2023 where the Manager will present the Company's financial results for the six month period to 30 September 2023.

The presentation will be hosted on the Investor Meet Company platform and is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9:00 a.m. the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and should "add to meet Augmentum Fintech plc" in order to register for the call at the following link:

https://www.investormeetcompany.com/augmentum-fintech-plc/register-investor Those who already follow Augmentum Fintech plc on the Investor Meet Company platform will automatically be invited.

Enquiries:

Augmentum FintechTim Levene, Portfolio ManagerGeorgie Hazell Kivell, Marketing and IR	+44 (0)20 3961 5420[email protected]
Quill PRNick Croysdill, Sarah Gibbons-Cook(Press and Media)	+44 (0)20 7466 5050[email protected]
Peel Hunt LLPLiz Yong, Luke Simpson, Huw Jeremy(Investment Banking)	+44 (0)20 7418 8900
Singer Capital MarketsHarry Gooden, Robert Peel, Alaina Wong(Investment Banking)	+44 (0)20 7496 3000
Frostrow Capital LLPPaul Griggs, Company Secretary	+44 (0)20 3709 8733

About Augmentum Fintech

Augmentum invests in fast growing fintech businesses that are disrupting the financial services sector. Augmentum is the UK's only publicly listed investment company focusing on the fintech sector in the UK and wider Europe, having launched on the main market of the London Stock Exchange in 2018, giving businesses access to patient capital and support, unrestricted by conventional fund timelines and giving public markets investors access to a largely privately held investment sector during its main period of growth.